Trials / Unknown
UnknownNCT02975661
Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 740 (actual)
- Sponsor
- Qidong Gaitianli Medicines Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Registration of patients after gastrointestinal cancer radical surgery, including the information of treatments, recurrence \& metastasis, adverse events,etc.
Detailed description
This study adopts a multicenter, open, and registered research method, and plans to include 840 cases, including 360 cases in the Huaier Granule test group, 360 cases in the radiotherapy and chemotherapy control group, and 120 cases in the blank group. Using natural grouping, the registered objects are not pre grouped or queue divided, and the diagnosis, treatment, efficacy, and safety of gastrointestinal malignant tumor patients are accurately recorded under real conditions.
Conditions
Timeline
- Start date
- 2017-02-04
- Primary completion
- 2023-10-20
- Completion
- 2024-02-01
- First posted
- 2016-11-29
- Last updated
- 2023-10-25
Locations
12 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02975661. Inclusion in this directory is not an endorsement.